L

Longevity Biotech

0 employees

Longevity Biotech is developing new therapeutic drug candidates, which may have direct clinical impacts on patients lives. All of our programs are based on our Hybridtide peptide scaffold technology. Hybridtides are designed for long-acting oral administration.

Investor insights

Funding rounds participated in

$316K sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2010

Funding rounds raised

Total raised

$316K

from 1 investors over 1 rounds

L

Longevity Biotech raised $316K on December 9, 2017

Investors: National Multiple Sclerosis Society (NMSS)